Response duration (RD) according to MRD status after combined immunochemotherapy. (A) RD according to MRD status in PB and/or BM after end of induction in MCL Younger and MCL Elderly patients. RD duration according to MRD status assessed in the PB (B) or BM (C) after induction treatment in both trials.